Quest Diagnostics Incorporated

NYSE:DGX

Medical - Diagnostics & Research

Healthcare
$259.69 -1.72%

-$3.41 today

Market cap
$28.57B
Beta
0.59
P/E (TTM)
20.9
EPS (TTM)
$9.31
Dividend yield
1.68%
52W Low $164.65High $213.50

Volume 1.30M

Average 0.91M

DGX Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Quest Diagnostics IncorporatedNYSE: DGX

Gross Margin · Q3 FY2026 · quarter ended Sep 2026

Gross margin holds steady near 33.6%

Gross margin was 33.6% in Q3 FY2026, down 0.1 pp from a year earlier. On a trailing-twelve-month basis it was 33.1%, down 0.2 pp year over year. Over 3 fiscal years it narrowed by 2.8 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
33.6%-0.1 pp QoQ
Last fiscal yearDec 2025
31.9%-0.9 pp YoY
LTMSep 2026
33.1%-0.2 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-0.1 pp——
1 year-0.9 pp——
3 years-2.8 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
31.9%
Year-over-year change
-0.9pp

Gross Margin vs competitors

How DGX compares with its peers on the latest reported figures

  • DGX's LTM Sep 2026 gross margin of 33.1% is the 6th highest of the 9 companies compared; the peer median is 57.0%.
  • Its year-over-year change of -0.2 pp is the 4th highest of 9, against a peer median of -0.3 pp.
  • Over three fiscal years its change of -2.8 pp compares with a peer median of -0.4 pp.
DGX Competitors Peer median
Gross Margin for DGX and competitors
Company Period LTM level YoY 3-year change
ILMNIllumina, Inc.LTM Jun 202666.8% -0.3 pp+1.9 pp
NTRANatera, Inc.LTM Jun 202665.3% +2.4 pp+20.5 pp
GHGuardant Health, Inc.LTM Sep 202665.2% +1.4 pp-0.8 pp
QGENQiagen N.V.LTM Jun 202661.8% -1.1 pp-2.9 pp
RVTYRevvity, Inc.LTM Jul 202652.1% -1.9 pp-0.1 pp
DGXQuest Diagnostics IncorporatedLTM Sep 202633.1% -0.2 pp-2.8 pp
LHLabcorp Holdings Inc.LTM Jun 202627.8% -0.3 pp-4.5 pp
RDNTRadNet, Inc.LTM Sep 20269.8% -1.6 pp-7.1 pp
GRALGRAIL, Inc.LTM Jun 2026-10.8% +45.7 pp+167.1 pp
Peer median (excluding DGX) 57.0%-0.3 pp-0.4 pp

Competitors are the stored peer set for DGX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue10.79B9.88B9.25B9.87B11.04B
Cost of Revenue6.58B6.45B6.2B6.63B7.51B
Gross Profit4.21B3.43B3.07B3.24B3.52B
Gross Margin39.0%34.7%33.2%32.9%31.9%
Research & Development00000
Selling, General & Admin1.73B1.87B1.62B1.77B1.97B
Operating Expenses1.83B2.01B1.81B1.9B1.92B
Depreciation & Amortization408M437M439M493M570M
EBITDA3.16B1.82B1.73B1.89B2.19B
EBITDA Margin29.3%18.4%18.7%19.2%19.9%
Operating Income2.38B1.43B1.26B1.35B1.6B
Operating Margin22.1%14.4%13.6%13.6%14.5%
Interest Income1M10M11M25M13M
Interest Expense152M148M163M226M277M
Other Income / Expenses296M(149M)(106M)(152M)(243M)
Income Before Tax2.68B1.28B1.16B1.19B1.36B
Pre-Tax Margin24.8%12.9%12.5%12.1%12.3%
Income Tax Expense597M264M248M273M314M
Net Income2B946M854M871M992M
Net Margin18.5%9.6%9.2%8.8%9.0%
EPS (Basic)15.908.127.597.808.87
EPS (Diluted)15.537.987.527.698.75
Weighted Avg Shares125M116M112M111M111M
Weighted Avg Shares (Diluted)128M118M113M113M113M

Quest Diagnostics Incorporated

NYSE:DGX

Intrinsic Alpha fair value

Locked

Current Price

$259.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.